1Department of Neurosurgery, Johns Hopkins Hospital, Baltimore, Maryland.
2Georgetown University School of Medicine, Washington, DC.
J Neurosurg. 2024 May 3;141(4):908-916. doi: 10.3171/2024.2.JNS232695. Print 2024 Oct 1.
The Glasgow Coma Scale-Pupils (GCS-P) score has been suggested to better predict patient outcomes compared with GCS alone, while avoiding the need for more complex clinical models. This study aimed to compare the prognostic ability of GCS-P versus GCS in a national cohort of traumatic subdural hematoma (SDH) patients.
Patient data were obtained from the National Trauma Data Bank (2017-2019). Inclusion criteria were traumatic SDH diagnosis with available data on presenting GCS score, pupillary reactivity, and discharge disposition. Patients with severe polytrauma or nonsurvivable head injury at presentation were excluded. Sensitivity, specificity, and area under the receiver operating characteristic curve (AUC) of GCS-P versus GCS scores for inpatient mortality prediction were evaluated across the entire cohort, as well as in subgroups based on age and traumatic brain injury (TBI) type (blunt vs penetrating). Calibration curves were plotted based on predicted probabilities and actual outcomes.
A total of 196,747 traumatic SDH patients met the study inclusion criteria. Sensitivity (0.707 vs 0.702), specificity (0.821 vs 0.823), and AUC (0.825 vs 0.814, p < 0.001) of GCS-P versus GCS scores for prediction of inpatient mortality were similar. Calibration curve analysis revealed that GCS scores slightly underestimated inpatient mortality risk, whereas GCS-P scores did not. In patients > 65 years of age with blunt TBI (51.9%, n = 102,148), both GCS-P and GCS scores underestimated inpatient mortality risk. In patients with penetrating TBI (2.4%, n = 4,710), the AUC of the GCS-P score was significantly higher (0.902 vs 0.851, p < 0.001). In this subgroup, both GCS-P and GCS scores underestimated inpatient mortality risk among patients with lower rates of observed mortality and overestimated risk among patients with higher rates of observed mortality. This effect was more pronounced in the GCS-P calibration curve.
The GCS-P score provides better short-term prognostication compared with the GCS score alone among traumatic SDH patients with penetrating TBI. The GCS-P score overestimates inpatient mortality risk among penetrating TBI patients with higher rates of observed mortality. For penetrating TBI patients, which comprised 2.4% of our SDH cohort, a low GCS-P score should not justify clinical nihilism or forgoing aggressive treatment.
与单独使用格拉斯哥昏迷量表(GCS)相比,格拉斯哥昏迷量表-瞳孔(GCS-P)评分被认为能更好地预测患者预后,同时避免使用更复杂的临床模型。本研究旨在比较全国创伤性硬脑膜下血肿(SDH)患者队列中 GCS-P 与 GCS 的预后能力。
从国家创伤数据库(2017-2019 年)中获取患者数据。纳入标准为创伤性 SDH 诊断,具有初始 GCS 评分、瞳孔反应和出院情况的可用数据。排除初始严重多发伤或不可存活的头部损伤的患者。评估了整个队列以及基于年龄和创伤性脑损伤(TBI)类型(钝性 vs 穿透性)的亚组中 GCS-P 与 GCS 评分对内科死亡率预测的敏感性、特异性和接受者操作特征曲线(ROC)下面积(AUC)。根据预测概率和实际结果绘制校准曲线。
共有 196747 例创伤性 SDH 患者符合研究纳入标准。GCS-P 与 GCS 评分对内科死亡率预测的敏感性(0.707 对 0.702)、特异性(0.821 对 0.823)和 AUC(0.825 对 0.814,p < 0.001)相似。校准曲线分析显示,GCS 评分略微低估了住院死亡率风险,而 GCS-P 评分则没有。在>65 岁的钝性 TBI 患者中(51.9%,n=102148),GCS-P 和 GCS 评分均低估了住院死亡率风险。在穿透性 TBI 患者中(2.4%,n=4710),GCS-P 评分的 AUC 显著更高(0.902 对 0.851,p < 0.001)。在该亚组中,GCS-P 和 GCS 评分均低估了观察死亡率较低的患者的住院死亡率风险,高估了观察死亡率较高的患者的风险。这种影响在 GCS-P 校准曲线中更为明显。
与单纯使用 GCS 评分相比,GCS-P 评分在穿透性 TBI 创伤性 SDH 患者中能提供更好的短期预后。GCS-P 评分高估了观察死亡率较高的穿透性 TBI 患者的住院死亡率风险。对于穿透性 TBI 患者,其构成了我们 SDH 队列的 2.4%,低 GCS-P 评分不应证明临床不作为或放弃积极治疗是合理的。